Open Startup has introduced The Science Road, a strategic direction intended to help African science, deep tech and research-led ventures progress from laboratory-based discovery toward commercially viable companies. Announced on June 29, 2026, the initiative coincides with the Tunis-founded nonprofit’s tenth anniversary and sharpens its focus on technologies spanning health, climate, artificial intelligence and related fields. The new model combines venture acceleration, early financing and partnerships to strengthen the links between African innovators, markets, investors and international collaborators.
A Decade of Ecosystem Building
Founded in Tunisia in 2016, Open Startup began as a university entrepreneurship competition and has since developed into a pan-African platform for venture creation, investment readiness and ecosystem development. The organization says it has supported more than 3,000 founders and 1,000 startups across over 20 African countries, while building a network of more than 500 mentors, advisors and experts. It has also trained over 300 coaches and connected entrepreneurs with investors, corporations, universities, policymakers and global partners.
A More Focused Operating Model
The Science Road brings Open Startup’s existing initiatives together under a single acceleration platform built around the specific needs of research-led ventures. Such companies often face longer product-development cycles, specialist technical requirements and a funding gap before their innovations can reach customers or demonstrate commercial potential. Open Startup’s revised structure aims to address these constraints by creating clearer routes for founders working on scientific breakthroughs to secure support, validate their markets and prepare for investment.
Supporting Ventures at Two Stages
The platform will operate through two pathways, separating founders at the pre-seed stage from businesses already approaching or operating at seed stage. The first will work with innovators translating research and novel technologies into investable companies, while the second will help seed-stage startups scale solutions that could address significant market and societal challenges. By distinguishing between those stages, Open Startup is positioning its services around the different technical, commercial and capital needs that emerge as a research project becomes a business.
Openers First Adds Early Financing
A central addition to the strategy is Openers First, an investment arm designed to back selected ventures emerging from Open Startup’s platform. It is intended to complement the nonprofit’s investment-readiness programs by providing an early financing layer for companies moving between pre-seed development and seed-stage growth. The organization also expects the initiative to contribute to its longer-term sustainability, as it expands support for ventures with the potential to create durable value.
Connecting Research to Markets Across Africa
Open Startup plans to deepen collaboration across African innovation ecosystems, including work with CERI, Stellenbosch University and LaunchLab in South Africa. The partnerships are expected to help research-led founders move technologies closer to market adoption, investment and industry engagement, extending Open Startup’s existing continental footprint from Tunis to South Africa. Its broader partner network includes KfW AfricaGrow, AfricInvest, the United States Department of State, the European Union, Digital Africa, Bpifrance, Sanofi Ventures and several academic institutions.
Founder and Chief Executive Officer Houda Ghozzi said the organization is entering its second decade with greater maturity, wider reach and a renewed ambition to connect African innovators with global opportunities. The Science Road reflects a bet that Africa’s next generation of high-growth ventures will require more than conventional startup support, particularly when commercializing scientific and technical research. Its effectiveness will depend on whether the platform can translate its ecosystem connections, acceleration programs and new capital capability into stronger pathways from discovery to scalable companies.